Health
New bird flu strain detected on poultry farm as experts monitor mutations
A new strain of bird flu (highly pathogenic avian influenza, or HPAI) has been detected on a duck farm in California.
The World Organisation for Animal Health (WOAH) reported the outbreak of the new strain, H5N9, earlier this week on its website.
The more common H5N1 strain was also found at the same farm, which is located in Merced County, according to reports.
BIRD FLU PROVES FATAL TO CATS: HERE’S HOW TO PROTECT YOUR PETS
“This is the first confirmed case of HPAI H5N9 in poultry in the United States,” WOAH wrote.
A new strain of bird flu (highly pathogenic avian influenza, or HPAI) has been detected on a duck farm in California. (iStock)
Health agencies are conducting “comprehensive epidemiological investigations and enhanced surveillance,” according to the statement.
David J. Cennimo, an associate professor of medicine and pediatrics in the Division of Infectious Diseases at Rutgers New Jersey Medical School, said this new strain could point to the “adaptability” of influenza viruses.
HAS A ‘QUADEMIC’ HIT THE US? 4 VIRAL INFECTIONS AND WHAT TO KNOW ABOUT THEM
“Birds are very susceptible to avian influenza in general. Some strains of the virus are mild, some deadly,” he told Fox News Digital.
H5N9 has been seen in the past, Cennimo noted, and generally causes mild illness in birds.
“Birds are very susceptible to avian influenza in general. Some strains of the virus are mild, some deadly,” an expert told Fox News Digital. (iStock)
“The ducks in California, however, were dying,” he said. “Genetic testing showed this H5N9 was different from historical samples and was, in fact, a reassortment.”
(Reassortment is the process by which influenza viruses swap gene segments, according to the National Institutes of Health.)
With influenza viruses, scientists name them based on the Hs and Ns (hemagglutinin and neuraminidase surface proteins), according to Cennimo.
There are “continual mutations” of flu strains, so not all H1 versions are the same, the doctor said.
There are “continual mutations” of flu strains, so not all H1 versions are the same, a doctor said. (iStock)
“This is why humans are getting influenza vaccines yearly, and you will see the strain compositions change some years, even though they remain H1N1 and H3N2,” he said.
“In this case, the H5 in the H5N9 was the H5 from the currently circulating H5N1 bird flu that is more pathogenic.”
“While H5N9 is not generally a very dangerous virus, we need to keep an eye on this new strain.”
With H5N9, he said, the virus appears to have switched its N1 and picked up an N9 from another virus.
This can happen when two different viruses simultaneously infect the same animal, he said.
Researchers become concerned when there are large outbreaks of bird flu in poultry farms, one expert noted. (iStock)
“While H5N9 is not generally a very dangerous virus, we need to keep an eye on this new strain,” Cennimo cautioned.
“To date, I am not aware of any human infections with H5N9. Again, this will be monitored.”
The jump from birds to humans
Dr. Jacob Glanville, CEO of Centivax, a San Francisco biotechnology company, told Fox News Digital, noted that birds are “constantly a reservoir” for many types of influenzas that normally do not infect people.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Researchers monitor them, as the bird flus have evolved to become human global pandemic strains multiple times in the past,” he told Fox News Digital. “In order to infect humans, they need to mutate in order to adapt from a bird to human host.”
To date, there have been 67 confirmed cases of human bird flu in the U.S. and one death, according to the CDC. (iStock)
Researchers become concerned when there are large outbreaks of bird flus in poultry farms, according to Glanville.
In addition to interfering with the food supply, having many infected birds in proximity to pigs, cows and humans greatly increases the risk of mutations that could spill over into “mammalian infections.”
For more Health articles, visit www.foxnews.com/health
“Currently, this is the main concern for H5N1,” he said. “Other reports of bird flu are worth monitoring but are currently low risk.”
To date, there have been 67 confirmed cases of human bird flu in the U.S. and one death, according to the Centers for Disease Control and Prevention (CDC).
NEWYou can now listen to Fox News articles!
A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period.
The personalized mRNA cancer therapy, called intismeran autogene, combined with the cancer immunotherapy drug KEYTRUDA (pembrolizumab), is a collaboration between Merck and Moderna.
The results from the phase 2b KEYNOTE-942 study were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on May 27.
CLICK HERE FOR MORE HEALTH STORIES
After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.
The researchers analyzed data from 157 patients with high-risk stage 3 and 4 melanoma whose cancer had been removed via surgery. The participants were split into two groups — one received the combo therapy and the other only received pembrolizumab, according to a press release.
The therapy was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone after a five-year follow-up. (iStock)
The findings revealed that the combination group saw benefits that were “sustained and durable over time.”
Intismeran autogene is designed using mutations identified in a patient’s own tumor, with the intention of teaching the immune system what the cancer looks like so that it can recognize and attack it.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
According to the researchers, intismeran is “well-tolerated” with a “manageable” safety profile.
The most commonly cited side effects of the personalized mRNA vaccine plus KEYTRUDA were fatigue, injection-site pain, chills, fever and headache. The researchers reported no new long-term safety concerns and no severe vaccine-related adverse events.
The combination therapy is currently being evaluated in a phase 3 study — the final confirmation stage.
Patients with late-stage melanoma have a “significant risk” of cancer recurrence, according to an expert. (iStock)
In a Merck press release from January, Kyle Holen, MD, Moderna’s senior vice president and head of development, oncology and therapeutics, noted that this data highlights the “potential of a prolonged benefit … in patients with resected high-risk melanoma.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“We continue to invest in our platform in oncology because of encouraging outcomes like these, which illustrate mRNA’s potential in cancer care,” he said.
Dr. Marjorie Green, senior vice president and head of oncology, global clinical development at Merck Research Laboratories, also commented that for many patients with stage 3 or 4 melanoma, there is a “significant risk of recurrence following surgery.”
Researchers confirmed that the combination therapy is currently being evaluated in a phase 3 study. (iStock)
“As such, demonstrating the longer-term potential of intismeran autogene and KEYTRUDA to reduce the risk of recurrence for certain patients with melanoma is a meaningful milestone,” she said.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The company cited encouraging five-year follow-up data and pointed to upcoming late-stage INTerpath trial results with Moderna in several hard-to-treat cancers.
NEWYou can now listen to Fox News articles!
An accidental lab discovery has opened the door to entirely new ways of preventing the flu.
While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells, SWNS reported.
By targeting the specific molecules the viruses rely on, scientists found that they could block them from entering new cells and halt their replication altogether.
5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS
Researchers say these “fundamental insights” into seasonal influenza highlight a clear path toward developing better preventive medications.
“The hope is that fundamental, curiosity-based research like this helps to pave the way for novel strategies to treat and prevent influenza infections,” principal investigator Dr. Emily Bruce, from the University of Vermont’s Larner College of Medicine, said in the SWNS report.
While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells. (iStock)
While several flu strains cause illness, H1N1 and H3N2 influenza A viruses are the most common. However, current flu tests cannot differentiate between them, and clinical treatments are identical for both.
Although vaccines and antivirals are available, Bruce noted a “dire” need for better medications to stop the virus from spreading cell to xxcell.
“You don’t get sick when a virus is in one cell,” he noted. “You get sick because a virus replicates itself and goes into many more cells.”
HOW LONG YOU’RE CONTAGIOUS WITH THE FLU — AND WHEN IT’S SAFE TO GO OUT
The study, which was published in The Journal of Virology, originally aimed to map how viral RNA segments are transported within cells to create new viral particles.
The team used H1N1 and H3N2 viruses isolated from the nasal passages of positive patients in 2022.
Clinical treatments remain identical for both primary strains of the flu virus. (iStock)
During the investigation, the team unexpectedly stumbled upon a cellular pathway that blocked the virus from entering lung cells, SWNS reported.
RESEARCHERS LOCKED FLU PATIENTS IN A HOTEL WITH HEALTHY ADULTS — NO ONE GOT SICK
The data revealed that when a specific human protein called Rab11B was depleted, H3N2 viruses failed to enter human lung cells. H1N1 viruses were completely unaffected.
Using reverse genetics, the team mapped this defect and uncovered a brand-new, H3N2-specific role for Rab11B during viral entry.
CLICK HERE FOR MORE HEALTH STORIES
This discovery challenged the scientific assumption that all flu viruses enter cells the same way.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Viruses are like pirates from different countries hijacking someone’s ship,” Bruce said. “Different viruses, like different types of pirates, use different methods to get onboard.”
This discovery challenged the scientific assumption that all flu viruses enter cells the same way. (iStock)
“We had previously thought that all flu viruses used the same way to get into a cell, but we discovered that this is not true,” she went on. “H1N1 and H3N2 need different proteins to get in, and if you get rid of the right protein, a specific virus can’t get in.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
While these findings identify a critical cellular pathway for viral entry, the study was conducted using isolated cells, the researchers acknowledged.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Further research is needed to determine whether blocking the protein is safe and effective within a live, complex human respiratory system.
Bruce and the team hope to conduct further research to determine whether this Rab11B-dependency is a fundamental property of H3N2, or if it’s a trait unique to currently circulating flu strains.
NEWYou can now listen to Fox News articles!
Eating processed meat like ham, sausage and bacon may be linked to a higher risk of certain types of cancer, according to new research.
While health organizations have already confirmed that processed meat can contribute to colon cancer, this study looked closer at cancers in the upper digestive tract, where the link has historically been less clear.
To understand these connections, researchers from the European Prospective Investigation into Cancer and Nutrition (EPIC), one of the world’s largest long-term nutrition and cancer cohorts, tracked the health and diets of 450,112 people across Europe for an average of 14 years.
FREQUENT HEARTBURN MAY BE A WARNING SIGN OF A MORE DANGEROUS CONDITION, DOCTOR SAYS
The study group included 131,426 men and 318,686 women, according to the study’s press release.
During the follow-up period, 876 people developed stomach cancer and 215 people developed esophageal adenocarcinoma, which is cancer of the tube connecting the mouth to the stomach.
For female participants, eating both processed meat and white meat was linked to an increased risk of developing the disease. (iStock)
Researchers tracked where the stomach cancers grew, separating them into the upper part of the stomach near the throat and the lower part of the stomach.
The researchers also sorted the tumors into two categories based on how the cancer cells appeared under a microscope: intestinal, which forms more organized structures, and diffuse, in which the cells are more scattered throughout the tissue.
BACTERIA IN YOUR MOUTH MAY TRAVEL TO THE GUT AND TRIGGER STOMACH CANCER, RESEARCH FINDS
After adjusting for other lifestyle factors, the researchers found that for every extra 30 grams of processed meat a person ate per day, their overall risk of stomach cancer went up by 9%. Eating that same extra 30 grams a day was also linked to a 13% higher risk of esophageal adenocarcinoma.
A standard single slice of regular deli-sliced ham or lunch meat averages around 28 grams, according to USDA data and nutritional tracking databases.
An extra 20 grams of white meat, such as chicken and turkey, was linked to a 12% higher risk of cancer in the main body of the stomach. (iStock)
An extra 20 grams of white meat, such as chicken or turkey, was linked to a 12% higher risk of cancer in the main body of the stomach, the researchers noted.
The study also revealed differences between men and women. For male participants, only processed meat showed a clear, statistically significant link to a higher risk of stomach cancer. For female participants, however, eating both processed meat and white meat was linked to an increased risk.
CLICK HERE FOR MORE HEALTH STORIES
These findings align with global health benchmarks, particularly those established by the World Health Organization’s International Agency for Research on Cancer.
The agency has long classified processed meat as a known human carcinogen, primarily due to its strong, well-documented links to colorectal cancer.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
However, health organizations have also consistently pointed to a potential, yet less definitive, relationship between these meats and cancers of the stomach.
Eating 30 grams of processed meat a day, or the equivalent to one slice of ham, was linked to a 13% higher risk of esophageal adenocarcinoma. (iStock)
Further scientific investigation is needed to confirm the findings and to account for other underlying risk factors, such as certain stomach infections, which could interact with dietary habits.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
A key limitation of the study is its reliance on self-reported diets, which can sometimes lead to inaccuracies in how participants recall their meat consumption over time, the researchers noted.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The findings were published in the International Journal of Cancer.
Fox News Digital reached out to the researchers requesting comment.
-
Connecticut3 minutes agoDriver Dies After Vehicle Plunges Into Water: Police: CT News
-
Delaware6 minutes agoA favorite Delaware ice cream spot is getting a major makeover
-
Florida11 minutes agoCFO tells Florida voters don’t believe ‘big government apologists’ hype on property tax
-
Georgia18 minutes agoArgentine tegus up to 56 sightings in GA. Have you seen these invaders?
-
Hawaii21 minutes agoHonolulu City Council adopts nearly $5B budget package | Honolulu Star-Advertiser
-
Idaho21 minutes agoCourt Clears Path For Idaho’s Critical Stibnite Antimony Mine
-
Illinois33 minutes agoSuburban Chicago man charged after Illinois Tollway worker killed on I-294
-
Indiana36 minutes agoWhat do Skylake Adventures Indiana tickets cost? When Sheridan water park opens, location, hours
